Feasibility of machine learning-based modeling and prediction using multiple centers data to assess intrahepatic cholangiocarcinoma outcomes

Abstract

Background and aims Currently, there are still no definitive consensus in the treatment of intrahepatic cholangiocarcinoma (iCCA). This study aimed to build a clinical decision support tool based on machine learning using the Surveillance, Epidemiology, and End Results (SEER) database and the data from the Fifth Medical Center of the PLA General Hospital in China. Methods 4,398 eligible patients from the SEER database and 504 eligible patients from the hospital data, who presented with histologically proven iCCA, were enrolled for modeling by cross-validation based on machine learning. All the models were trained using the open-source Python library scikit-survival version 0.16.0. Shapley additive explanations method was used to help clinicians better understand the obtained results. Permutation importance was calculated using library ELI5. Results All involved treatment modalities could contribute to a better prognosis. Three models were derived and tested using different data sources, with concordance indices of 0.67, 0.69, and 0.73, respectively. The prediction results were consistent with those under actual situations involving randomly selected patients. Model 2, trained using the hospital data, was selected to develop an online tool, due to its advantage in predicting short-term prognosis. Conclusion The prediction model and tool established in this study can be applied to predict the prognosis of iCCA after treatment by inputting the patient’s clinical parameters or TNM stages and treatment options, thus contributing to optimal clinical decisions. KEY MESSAGES A prognostic model related to disease staging and treatment mode was conducted using the method of machine learning, based on the big data of multi centers. The online calculator can predict the short-term survival prognosis of intrahepatic cholangiocarcinoma, thus, help to make the best clinical decision. The online calculator built to calculate the mortality risk and overall survival can be easily obtained and applied.

Deep Learning for the Prediction of the Survival of Midline Diffuse Glioma with an H3K27M Alteration

“…Traditional machine learning and deep learning constitute artificial intelligence, which is currently widely used in the medical field [14,15]. Zhou et al [16] conducted survival analysis on intrahepatic cholangiocarcinoma using multicenter data based on machine learning modeling and prediction and achieved good results. In 2018, Katzman et al [17] proposed DeepSurv, which is a survival prediction method based on neural networks.…”

Application of AI on cholangiocarcinoma

“…Zhou et al. ( 93 ) established three RF models and developed an online tool, with an AUC of 0.7478. Serum albumin-to-fibrinogen ratio and CA 19-9 were used to develop the DeepSurv model to predict the prognosis of ECC and guide individualized postoperative chemotherapy as shown in the study by Wang et al.…”

The Effectiveness of Metabolic Bariatric Surgery in Preventing Gynecologic Cancer - from Pathophysiology to Clinical Outcomes

“…However, we acknowledge the technical difficulty, the considerable cost, and the potential ethical issues of carrying out such meta-analyses in cancer survivors. The implementation of novel research methods, such as the analysis of big data contained in population-based studies and registries with machine learning 132 , 133 , might serve as reliable alternatives for investigating the role of MBS in preventing gynecologic cancer recurrence and extending survivorship.…”